 | • レポートコード：QAF27540 • 出版社/出版日：QYResearch / 2021年4月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、138ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の急性片頭痛薬市場について種類別（トリプタン、NSAID、その他）、用途別（病院薬局、ドラッグストア）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・急性片頭痛薬市場の概要 ・世界の主要地域別急性片頭痛薬市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の急性片頭痛薬市場規模2016-2021：種類別（トリプタン、NSAID、その他） ・世界の急性片頭痛薬市場予測2012-2027：種類別（トリプタン、NSAID、その他） ・世界の急性片頭痛薬市場規模2016-2021：用途別（病院薬局、ドラッグストア） ・世界の急性片頭痛薬市場予測2012-2027：用途別（病院薬局、ドラッグストア） ・急性片頭痛薬のアメリカ市場規模と予測2016-2021 ・急性片頭痛薬のヨーロッパ市場規模と予測2016-2021 ・急性片頭痛薬の中国市場規模と予測2016-2021 ・急性片頭痛薬の日本市場規模と予測2016-2021 ・急性片頭痛薬の東南アジア市場規模と予測2016-2021 ・急性片頭痛薬のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （GSK、Teva、Pfizer、Novartis、Sun Pharma、Grunenthal、Endo Pharmaceuticals、Merck、J & J） ・急性片頭痛薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・急性片頭痛薬の市場動向・機会・課題 ・調査の結論 |
A migraine is an episodic and unpredictable headache disorder that presents with disabling attack. Migraine is one of the most frequent disabling neurological conditions with a major impact on the patient’s quality of life. Migraine has been described as a chronic disorder that characterized with attacks. Attacks are characterized by moderate–severe, often unilateral, pulsating headache attacks, typically lasting 4 to 72 hours.
The top 3 manufacturers held about 29.5% of the market share in 2019, while top 5 hold 41.93%.
Market Analysis and Insights: Global Acute Migraine Drugs Market
The global Acute Migraine Drugs market was valued at US$ 2104.4 in 2020 and will reach US$ 3211.7 million by the end of 2027, growing at a CAGR of 7.3% during 2022-2027.
Global Acute Migraine Drugs Scope and Market Size
The global Acute Migraine Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Acute Migraine Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Triptans
NSAIDs
Others
The proportion of triptans in 2019 is about 79.59% market share.
Segment by Application
Hospital Pharmacies
Drug Stores
The proportion of hospitals in 2019 is about 62.93%.
The Acute Migraine Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Acute Migraine Drugs market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
GSK
Teva
Pfizer
Novartis
Sun Pharma
Grunenthal
Endo Pharmaceuticals
Merck
J & J
1 Acute Migraine Drugs Market Overview
1.1 Acute Migraine Drugs Product Scope
1.2 Acute Migraine Drugs Segment by Type
1.2.1 Global Acute Migraine Drugs Sales by Type (2016 & 2021 & 2027)
1.2.2 Triptans
1.2.3 NSAIDs
1.2.4 Others
1.3 Acute Migraine Drugs Segment by Application
1.3.1 Global Acute Migraine Drugs Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores
1.4 Acute Migraine Drugs Market Estimates and Forecasts (2016-2027)
1.4.1 Global Acute Migraine Drugs Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Acute Migraine Drugs Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Acute Migraine Drugs Price Trends (2016-2027)
2 Acute Migraine Drugs Estimates and Forecasts by Region
2.1 Global Acute Migraine Drugs Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Acute Migraine Drugs Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Acute Migraine Drugs Sales Market Share by Region (2016-2021)
2.2.2 Global Acute Migraine Drugs Revenue Market Share by Region (2016-2021)
2.3 Global Acute Migraine Drugs Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Acute Migraine Drugs Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Acute Migraine Drugs Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Acute Migraine Drugs Estimates and Projections (2016-2027)
2.4.2 Europe Acute Migraine Drugs Estimates and Projections (2016-2027)
2.4.3 China Acute Migraine Drugs Estimates and Projections (2016-2027)
2.4.4 Japan Acute Migraine Drugs Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Acute Migraine Drugs Estimates and Projections (2016-2027)
2.4.6 India Acute Migraine Drugs Estimates and Projections (2016-2027)
3 Global Acute Migraine Drugs Competition Landscape by Players
3.1 Global Top Acute Migraine Drugs Players by Sales (2016-2021)
3.2 Global Top Acute Migraine Drugs Players by Revenue (2016-2021)
3.3 Global Acute Migraine Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Acute Migraine Drugs as of 2020)
3.4 Global Acute Migraine Drugs Average Price by Company (2016-2021)
3.5 Manufacturers Acute Migraine Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Acute Migraine Drugs Market Size by Type
4.1 Global Acute Migraine Drugs Historic Market Review by Type (2016-2021)
4.1.1 Global Acute Migraine Drugs Sales Market Share by Type (2016-2021)
4.1.2 Global Acute Migraine Drugs Revenue Market Share by Type (2016-2021)
4.1.3 Global Acute Migraine Drugs Price by Type (2016-2021)
4.2 Global Acute Migraine Drugs Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Acute Migraine Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Acute Migraine Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Global Acute Migraine Drugs Price Forecast by Type (2022-2027)
5 Global Acute Migraine Drugs Market Size by Application
5.1 Global Acute Migraine Drugs Historic Market Review by Application (2016-2021)
5.1.1 Global Acute Migraine Drugs Sales Market Share by Application (2016-2021)
5.1.2 Global Acute Migraine Drugs Revenue Market Share by Application (2016-2021)
5.1.3 Global Acute Migraine Drugs Price by Application (2016-2021)
5.2 Global Acute Migraine Drugs Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Acute Migraine Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Acute Migraine Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Acute Migraine Drugs Price Forecast by Application (2022-2027)
6 North America Acute Migraine Drugs Market Facts & Figures
6.1 North America Acute Migraine Drugs Sales by Company
6.1.1 North America Acute Migraine Drugs Sales by Company (2016-2021)
6.1.2 North America Acute Migraine Drugs Revenue by Company (2016-2021)
6.2 North America Acute Migraine Drugs Sales Breakdown by Type
6.2.1 North America Acute Migraine Drugs Sales Breakdown by Type (2016-2021)
6.2.2 North America Acute Migraine Drugs Sales Breakdown by Type (2022-2027)
6.3 North America Acute Migraine Drugs Sales Breakdown by Application
6.3.1 North America Acute Migraine Drugs Sales Breakdown by Application (2016-2021)
6.3.2 North America Acute Migraine Drugs Sales Breakdown by Application (2022-2027)
7 Europe Acute Migraine Drugs Market Facts & Figures
7.1 Europe Acute Migraine Drugs Sales by Company
7.1.1 Europe Acute Migraine Drugs Sales by Company (2016-2021)
7.1.2 Europe Acute Migraine Drugs Revenue by Company (2016-2021)
7.2 Europe Acute Migraine Drugs Sales Breakdown by Type
7.2.1 Europe Acute Migraine Drugs Sales Breakdown by Type (2016-2021)
7.2.2 Europe Acute Migraine Drugs Sales Breakdown by Type (2022-2027)
7.3 Europe Acute Migraine Drugs Sales Breakdown by Application
7.3.1 Europe 138 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 138 Sales Breakdown by Application (2022-2027)
8 China Acute Migraine Drugs Market Facts & Figures
8.1 China Acute Migraine Drugs Sales by Company
8.1.1 China Acute Migraine Drugs Sales by Company (2016-2021)
8.1.2 China Acute Migraine Drugs Revenue by Company (2016-2021)
8.2 China Acute Migraine Drugs Sales Breakdown by Type
8.2.1 China Acute Migraine Drugs Sales Breakdown by Type (2016-2021)
8.2.2 China Acute Migraine Drugs Sales Breakdown by Type (2022-2027)
8.3 China Acute Migraine Drugs Sales Breakdown by Application
8.3.1 China 243 Sales Breakdown by Application (2016-2021)
8.3.2 China 243 Sales Breakdown by Application (2022-2027)
9 Japan Acute Migraine Drugs Market Facts & Figures
9.1 Japan Acute Migraine Drugs Sales by Company
9.1.1 Japan Acute Migraine Drugs Sales by Company (2016-2021)
9.1.2 Japan Acute Migraine Drugs Revenue by Company (2016-2021)
9.2 Japan Acute Migraine Drugs Sales Breakdown by Type
9.2.1 Japan Acute Migraine Drugs Sales Breakdown by Type (2016-2021)
9.2.2 Japan Acute Migraine Drugs Sales Breakdown by Type (2022-2027)
9.3 Japan Acute Migraine Drugs Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Acute Migraine Drugs Market Facts & Figures
10.1 Southeast Asia Acute Migraine Drugs Sales by Company
10.1.1 Southeast Asia Acute Migraine Drugs Sales by Company (2016-2021)
10.1.2 Southeast Asia Acute Migraine Drugs Revenue by Company (2016-2021)
10.2 Southeast Asia Acute Migraine Drugs Sales Breakdown by Type
10.2.1 Southeast Asia Acute Migraine Drugs Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Acute Migraine Drugs Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Acute Migraine Drugs Sales Breakdown by Application
10.3.1 Southeast Asia K Unit Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Unit Sales Breakdown by Application (2022-2027)
11 India Acute Migraine Drugs Market Facts & Figures
11.1 India Acute Migraine Drugs Sales by Company
11.1.1 India Acute Migraine Drugs Sales by Company (2016-2021)
11.1.2 India Acute Migraine Drugs Revenue by Company (2016-2021)
11.2 India Acute Migraine Drugs Sales Breakdown by Type
11.2.1 India Acute Migraine Drugs Sales Breakdown by Type (2016-2021)
11.2.2 India Acute Migraine Drugs Sales Breakdown by Type (2022-2027)
11.3 India Acute Migraine Drugs Sales Breakdown by Application
11.3.1 India Acute Migraine Drugs Sales Breakdown by Application (2016-2021)
11.3.2 India Acute Migraine Drugs Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Acute Migraine Drugs Business
12.1 GSK
12.1.1 GSK Corporation Information
12.1.2 GSK Business Overview
12.1.3 GSK Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 GSK Acute Migraine Drugs Products Offered
12.1.5 GSK Recent Development
12.2 Teva
12.2.1 Teva Corporation Information
12.2.2 Teva Business Overview
12.2.3 Teva Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Teva Acute Migraine Drugs Products Offered
12.2.5 Teva Recent Development
12.3 Pfizer
12.3.1 Pfizer Corporation Information
12.3.2 Pfizer Business Overview
12.3.3 Pfizer Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Pfizer Acute Migraine Drugs Products Offered
12.3.5 Pfizer Recent Development
12.4 Novartis
12.4.1 Novartis Corporation Information
12.4.2 Novartis Business Overview
12.4.3 Novartis Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Novartis Acute Migraine Drugs Products Offered
12.4.5 Novartis Recent Development
12.5 Sun Pharma
12.5.1 Sun Pharma Corporation Information
12.5.2 Sun Pharma Business Overview
12.5.3 Sun Pharma Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Sun Pharma Acute Migraine Drugs Products Offered
12.5.5 Sun Pharma Recent Development
12.6 Grunenthal
12.6.1 Grunenthal Corporation Information
12.6.2 Grunenthal Business Overview
12.6.3 Grunenthal Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Grunenthal Acute Migraine Drugs Products Offered
12.6.5 Grunenthal Recent Development
12.7 Endo Pharmaceuticals
12.7.1 Endo Pharmaceuticals Corporation Information
12.7.2 Endo Pharmaceuticals Business Overview
12.7.3 Endo Pharmaceuticals Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Endo Pharmaceuticals Acute Migraine Drugs Products Offered
12.7.5 Endo Pharmaceuticals Recent Development
12.8 Merck
12.8.1 Merck Corporation Information
12.8.2 Merck Business Overview
12.8.3 Merck Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Merck Acute Migraine Drugs Products Offered
12.8.5 Merck Recent Development
12.9 J & J
12.9.1 J & J Corporation Information
12.9.2 J & J Business Overview
12.9.3 J & J Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 J & J Acute Migraine Drugs Products Offered
12.9.5 J & J Recent Development
13 Acute Migraine Drugs Manufacturing Cost Analysis
13.1 Acute Migraine Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Acute Migraine Drugs
13.4 Acute Migraine Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Acute Migraine Drugs Distributors List
14.3 Acute Migraine Drugs Customers
15 Market Dynamics
15.1 Acute Migraine Drugs Market Trends
15.2 Acute Migraine Drugs Drivers
15.3 Acute Migraine Drugs Market Challenges
15.4 Acute Migraine Drugs Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Acute Migraine Drugs Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Acute Migraine Drugs Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Acute Migraine Drugs Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Acute Migraine Drugs Sales (K Unit) by Region (2016-2021)
Table 5. Global Acute Migraine Drugs Sales Market Share by Region (2016-2021)
Table 6. Global Acute Migraine Drugs Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Acute Migraine Drugs Revenue Share by Region (2016-2021)
Table 8. Global Acute Migraine Drugs Sales (K Unit) Forecast by Region (2022-2027)
Table 9. Global Acute Migraine Drugs Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Acute Migraine Drugs Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Acute Migraine Drugs Revenue Share Forecast by Region (2022-2027)
Table 12. Global Acute Migraine Drugs Sales (K Unit) of Key Companies (2016-2021)
Table 13. Global Acute Migraine Drugs Sales Share by Company (2016-2021)
Table 14. Global Acute Migraine Drugs Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Acute Migraine Drugs Revenue Share by Company (2016-2021)
Table 16. Global Acute Migraine Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Migraine Drugs as of 2020)
Table 17. Global Acute Migraine Drugs Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Acute Migraine Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers Acute Migraine Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Acute Migraine Drugs Sales (K Unit) by Type (2016-2021)
Table 22. Global Acute Migraine Drugs Sales Share by Type (2016-2021)
Table 23. Global Acute Migraine Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Acute Migraine Drugs Price (USD/Unit) by Type (2016-2021)
Table 25. Global Acute Migraine Drugs Sales Share by Type (2022-2027)
Table 26. Global Acute Migraine Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Acute Migraine Drugs Revenue Share by Type (2022-2027)
Table 28. Global Acute Migraine Drugs Price (USD/Unit) by Type (2022-2027)
Table 29. Global Acute Migraine Drugs Sales (K Unit) by Application (2016-2021)
Table 30. Global Acute Migraine Drugs Sales Share by Application (2016-2021)
Table 31. Global Acute Migraine Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Acute Migraine Drugs Price (USD/Unit) by Application (2016-2021)
Table 33. Global Acute Migraine Drugs Sales (K Unit) by Application (2022-2027)
Table 34. Global Acute Migraine Drugs Sales Share by Application (2022-2027)
Table 35. Global Acute Migraine Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Acute Migraine Drugs Revenue Share by Application (2022-2027)
Table 37. Global Acute Migraine Drugs Price (USD/Unit) by Application (2022-2027)
Table 38. North America Acute Migraine Drugs Sales (K Unit) by Company (2016-2021)
Table 39. North America Acute Migraine Drugs Sales Market Share by Company (2016-2021)
Table 40. North America Acute Migraine Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Acute Migraine Drugs Revenue Market Share by Company (2016-2021)
Table 42. North America Acute Migraine Drugs Sales by Type (2016-2021) & (K Unit)
Table 43. North America Acute Migraine Drugs Sales Market Share by Type (2016-2021)
Table 44. North America Acute Migraine Drugs Sales by Type (2022-2027) & (K Unit)
Table 45. North America Acute Migraine Drugs Sales Market Share by Type (2022-2027)
Table 46. North America Acute Migraine Drugs Sales by Application (2016-2021) & (K Unit)
Table 47. North America Acute Migraine Drugs Sales Market Share by Application (2016-2021)
Table 48. North America Acute Migraine Drugs Sales by Application (2022-2027) & (K Unit)
Table 49. North America Acute Migraine Drugs Sales Market Share by Application (2022-2027)
Table 50. Europe Acute Migraine Drugs Sales (K Unit) by Company (2016-2021)
Table 51. Europe Acute Migraine Drugs Sales Market Share by Company (2016-2021)
Table 52. Europe Acute Migraine Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Acute Migraine Drugs Revenue Market Share by Company (2016-2021)
Table 54. Europe Acute Migraine Drugs Sales by Type (2016-2021) & (K Unit)
Table 55. Europe Acute Migraine Drugs Sales Market Share by Type (2016-2021)
Table 56. Europe Acute Migraine Drugs Sales by Type (2022-2027) & (K Unit)
Table 57. Europe Acute Migraine Drugs Sales Market Share by Type (2022-2027)
Table 58. Europe Acute Migraine Drugs Sales by Application (2016-2021) & (K Unit)
Table 59. Europe Acute Migraine Drugs Sales Market Share by Application (2016-2021)
Table 60. Europe Acute Migraine Drugs Sales by Application (2022-2027) & (K Unit)
Table 61. Europe Acute Migraine Drugs Sales Market Share by Application (2022-2027)
Table 62. China Acute Migraine Drugs Sales (K Unit) by Company (2016-2021)
Table 63. China Acute Migraine Drugs Sales Market Share by Company (2016-2021)
Table 64. China Acute Migraine Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Acute Migraine Drugs Revenue Market Share by Company (2016-2021)
Table 66. China Acute Migraine Drugs Sales by Type (2016-2021) & (K Unit)
Table 67. China Acute Migraine Drugs Sales Market Share by Type (2016-2021)
Table 68. China Acute Migraine Drugs Sales by Type (2022-2027) & (K Unit)
Table 69. China Acute Migraine Drugs Sales Market Share by Type (2022-2027)
Table 70. China Acute Migraine Drugs Sales by Application (2016-2021) & (K Unit)
Table 71. China Acute Migraine Drugs Sales Market Share by Application (2016-2021)
Table 72. China Acute Migraine Drugs Sales by Application (2022-2027) & (K Unit)
Table 73. China Acute Migraine Drugs Sales Market Share by Application (2022-2027)
Table 74. Japan Acute Migraine Drugs Sales (K Unit) by Company (2016-2021)
Table 75. Japan Acute Migraine Drugs Sales Market Share by Company (2016-2021)
Table 76. Japan Acute Migraine Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Acute Migraine Drugs Revenue Market Share by Company (2016-2021)
Table 78. Japan Acute Migraine Drugs Sales by Type (2016-2021) & (K Unit)
Table 79. Japan Acute Migraine Drugs Sales Market Share by Type (2016-2021)
Table 80. Japan Acute Migraine Drugs Sales by Type (2022-2027) & (K Unit)
Table 81. Japan Acute Migraine Drugs Sales Market Share by Type (2022-2027)
Table 82. Japan Acute Migraine Drugs Sales by Application (2016-2021) & (K Unit)
Table 83. Japan Acute Migraine Drugs Sales Market Share by Application (2016-2021)
Table 84. Japan Acute Migraine Drugs Sales by Application (2022-2027) & (K Unit)
Table 85. Japan Acute Migraine Drugs Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Acute Migraine Drugs Sales (K Unit) by Company (2016-2021)
Table 87. Southeast Asia Acute Migraine Drugs Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Acute Migraine Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Acute Migraine Drugs Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Acute Migraine Drugs Sales by Type (2016-2021) & (K Unit)
Table 91. Southeast Asia Acute Migraine Drugs Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Acute Migraine Drugs Sales by Type (2022-2027) & (K Unit)
Table 93. Southeast Asia Acute Migraine Drugs Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Acute Migraine Drugs Sales by Application (2016-2021) & (K Unit)
Table 95. Southeast Asia Acute Migraine Drugs Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Acute Migraine Drugs Sales by Application (2022-2027) & (K Unit)
Table 97. Southeast Asia Acute Migraine Drugs Sales Market Share by Application (2022-2027)
Table 98. India Acute Migraine Drugs Sales (K Unit) by Company (2016-2021)
Table 99. India Acute Migraine Drugs Sales Market Share by Company (2016-2021)
Table 100. India Acute Migraine Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Acute Migraine Drugs Revenue Market Share by Company (2016-2021)
Table 102. India Acute Migraine Drugs Sales by Type (2016-2021) & (K Unit)
Table 103. India Acute Migraine Drugs Sales Market Share by Type (2016-2021)
Table 104. India Acute Migraine Drugs Sales by Type (2022-2027) & (K Unit)
Table 105. India Acute Migraine Drugs Sales Market Share by Type (2022-2027)
Table 106. India Acute Migraine Drugs Sales by Application (2016-2021) & (K Unit)
Table 107. India Acute Migraine Drugs Sales Market Share by Application (2016-2021)
Table 108. India Acute Migraine Drugs Sales by Application (2022-2027) & (K Unit)
Table 109. India Acute Migraine Drugs Sales Market Share by Application (2022-2027)
Table 110. GSK Corporation Information
Table 111. GSK Description and Business Overview
Table 112. GSK Acute Migraine Drugs Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. GSK Acute Migraine Drugs Product
Table 114. GSK Recent Development
Table 115. Teva Corporation Information
Table 116. Teva Description and Business Overview
Table 117. Teva Acute Migraine Drugs Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Teva Acute Migraine Drugs Product
Table 119. Teva Recent Development
Table 120. Pfizer Corporation Information
Table 121. Pfizer Description and Business Overview
Table 122. Pfizer Acute Migraine Drugs Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Pfizer Acute Migraine Drugs Product
Table 124. Pfizer Recent Development
Table 125. Novartis Corporation Information
Table 126. Novartis Description and Business Overview
Table 127. Novartis Acute Migraine Drugs Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Novartis Acute Migraine Drugs Product
Table 129. Novartis Recent Development
Table 130. Sun Pharma Corporation Information
Table 131. Sun Pharma Description and Business Overview
Table 132. Sun Pharma Acute Migraine Drugs Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Sun Pharma Acute Migraine Drugs Product
Table 134. Sun Pharma Recent Development
Table 135. Grunenthal Corporation Information
Table 136. Grunenthal Description and Business Overview
Table 137. Grunenthal Acute Migraine Drugs Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Grunenthal Acute Migraine Drugs Product
Table 139. Grunenthal Recent Development
Table 140. Endo Pharmaceuticals Corporation Information
Table 141. Endo Pharmaceuticals Description and Business Overview
Table 142. Endo Pharmaceuticals Acute Migraine Drugs Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Endo Pharmaceuticals Acute Migraine Drugs Product
Table 144. Endo Pharmaceuticals Recent Development
Table 145. Merck Corporation Information
Table 146. Merck Acute Migraine Drugs Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Merck Description and Business Overview
Table 148. Merck Acute Migraine Drugs Product
Table 149. Merck Recent Development
Table 150. J & J Corporation Information
Table 151. J & J Acute Migraine Drugs Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. J & J Description and Business Overview
Table 153. J & J Acute Migraine Drugs Product
Table 154. J & J Recent Development
Table 155. Production Base and Market Concentration Rate of Raw Material
Table 156. Key Suppliers of Raw Materials
Table 157. Acute Migraine Drugs Distributors List
Table 158. Acute Migraine Drugs Customers List
Table 159. Acute Migraine Drugs Market Trends
Table 160. Acute Migraine Drugs Market Drivers
Table 161. Acute Migraine Drugs Market Challenges
Table 162. Acute Migraine Drugs Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Acute Migraine Drugs Product Picture
Figure 2. Global Acute Migraine Drugs Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Acute Migraine Drugs Sales Market Share by Application in 2021 & 2027
Figure 6. Hospital Pharmacies Examples
Figure 7. Drug Stores Examples
Figure 8. Global Acute Migraine Drugs Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Acute Migraine Drugs Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global Acute Migraine Drugs Sales (K Unit) Growth Rate (2016-2027)
Figure 11. Global Acute Migraine Drugs Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 12. Global Acute Migraine Drugs Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global Acute Migraine Drugs Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America Acute Migraine Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America Acute Migraine Drugs Sales (K Unit) Growth Rate (2016-2027)
Figure 16. Europe Acute Migraine Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe Acute Migraine Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China Acute Migraine Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China Acute Migraine Drugs Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan Acute Migraine Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan Acute Migraine Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia Acute Migraine Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Acute Migraine Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India Acute Migraine Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. India Acute Migraine Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Global 5 Largest Acute Migraine Drugs Players Market Share by Revenue in Acute Migraine Drugs: 2016 & 2020
Figure 27. Acute Migraine Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Acute Migraine Drugs Revenue Share by Type (2016-2021)
Figure 29. Global Acute Migraine Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 30. Global Acute Migraine Drugs Revenue Share by Application (2016-2021)
Figure 31. Global Acute Migraine Drugs Revenue Growth Rate by Application in 2016 & 2020
Figure 32. North America Acute Migraine Drugs Sales Market Share by Type in 2020
Figure 33. North America Acute Migraine Drugs Sales Market Share by Application in 2020
Figure 34. Europe Acute Migraine Drugs Sales Market Share by Type in 2020
Figure 35. Europe Acute Migraine Drugs Sales Market Share by Application in 2020
Figure 36. China Acute Migraine Drugs Sales Market Share by Type in 2020
Figure 37. China Acute Migraine Drugs Sales Market Share by Application in 2020
Figure 38. Japan Acute Migraine Drugs Sales Market Share by Type in 2020
Figure 39. Japan Acute Migraine Drugs Sales Market Share by Application in 2020
Figure 40. Southeast Asia Acute Migraine Drugs Sales Market Share by Type in 2020
Figure 41. Southeast Asia Acute Migraine Drugs Sales Market Share by Application in 2020
Figure 42. India Acute Migraine Drugs Sales Market Share by Type in 2020
Figure 43. India Acute Migraine Drugs Sales Market Share by Application in 2020
Figure 44. Key Raw Materials Price Trend
Figure 45. Manufacturing Cost Structure of Acute Migraine Drugs
Figure 46. Manufacturing Process Analysis of Acute Migraine Drugs
Figure 47. Acute Migraine Drugs Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
片頭痛治療薬のグローバル市場調査 2019年 The global Migraine Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Migraine Drugs volume and value at global level, regional level and company level. From a global perspective, this report re…- 世界の急性興奮＆攻撃性用医薬品市場規模・現状・予測（2021年-2027年） With acute agitation and aggression being a common symptom among patients suffering from various types of mental illnesses, the healthcare industry is expending efforts towards developing effective panaceas. Market Analysis and Insights: Global Acute Agitation and Aggression Drugs Market The global …
- 世界の急性虚血性脳卒中用医薬品市場規模・現状・予測（2021年-2027年） Acute Ischemic Stroke (CIS), also known as Cerebral Infarction (CI), is due to the occlusion of the Cerebral artery caused by the Infarction of brain tissue, accompanied by damage to neurons, astrocytes, oligodendrocytes, is the modern society leading to death and disability of the most important ce…
- 急性虚血性脳卒中薬のグローバル市場：規模・現状・予測2019-2025 Acute Ischemic Stroke (CIS), also known as Cerebral Infarction (CI), is due to the occlusion of the Cerebral artery caused by the Infarction of brain tissue, accompanied by damage to neurons, astrocytes, oligodendrocytes, is the modern society leading to death and disability of the most important ce…
- 急性虚血性脳卒中薬のグローバル市場：規模・現状・予測2019-2025 Acute Ischemic Stroke (CIS), also known as Cerebral Infarction (CI), is due to the occlusion of the Cerebral artery caused by the Infarction of brain tissue, accompanied by damage to neurons, astrocytes, oligodendrocytes, is the modern society leading to death and disability of the most important ce…